Abstract 4706: Evaluating the efficacy of RAS(ON) inhibitor RMC-6236 combined with chemotherapy and other targeted therapies in 3D models involving patients with KRAS-mutated pancreatic cancerTaylor Bargenquast, Sunil Sharma, Alexis Weston et al.|Cancer Research|2025Cited by 1
Preclinical Proof of Concept for a personalized SNAP <sup>TM</sup> -TIL (Specific Neo-Antigen Peptides -TIL) therapy platformTithi Ghosh, Sunil Sharma, Erin Kelley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Abstract 3900: Tegavivint, a first-in-class TBL1 inhibitor demonstrates potent activity in WNT-driven colorectal cancers.Raffaella Soldi, Sunil Sharma, Tithi Ghosh Halder et al.|Cancer Research|2026Cited by 0